181 related articles for article (PubMed ID: 10495384)
1. Incidence of residual basal cell carcinoma in patients who appear tumor free after biopsy.
Holmkvist KA; Rogers GS; Dahl PR
J Am Acad Dermatol; 1999 Oct; 41(4):600-5. PubMed ID: 10495384
[TBL] [Abstract][Full Text] [Related]
2. Residual skin cancer after preoperative biopsy: evaluation by Mohs micrographic surgery.
Alcalay J; Alkalay R; Hazaz B
Int J Dermatol; 2004 Jun; 43(6):456-8. PubMed ID: 15186232
[TBL] [Abstract][Full Text] [Related]
3. Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer.
Cohen PR; Schulze KE; Nelson BR
Dermatol Surg; 2006 Apr; 32(4):542-51. PubMed ID: 16681663
[TBL] [Abstract][Full Text] [Related]
4. The use of antidesmoglein stains in Mohs micrographic surgery. A potential aid for the differentiation of basal cell carcinoma from horizontal sections of the hair follicle and folliculocentric basaloid proliferation.
Krunic AL; Garrod DR; Viehman GE; Madani S; Buchanan MD; Clark RE
Dermatol Surg; 1997 Jun; 23(6):463-8. PubMed ID: 9217798
[TBL] [Abstract][Full Text] [Related]
5. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
[TBL] [Abstract][Full Text] [Related]
6. Histological evaluation of residual basal cell carcinoma after shave biopsy prior to Mohs micrographic surgery.
Alcalay J; Alkalay R
J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):839-41. PubMed ID: 21054570
[TBL] [Abstract][Full Text] [Related]
7. Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study.
Hendrix JD; Parlette HL
Dermatol Surg; 1996 Jun; 22(6):535-9. PubMed ID: 8646468
[TBL] [Abstract][Full Text] [Related]
8. Dense inflammation does not mask residual primary basal cell carcinoma during Mohs micrographic surgery.
Katz KH; Helm KF; Billingsley EM; Maloney ME
J Am Acad Dermatol; 2001 Aug; 45(2):231-8. PubMed ID: 11464184
[TBL] [Abstract][Full Text] [Related]
9. An assessment of incomplete facial Basal cell carcinoma excision.
Shah SA; Obaidullah ; Fahimullah
J Coll Physicians Surg Pak; 2005 Mar; 15(3):149-51. PubMed ID: 15808092
[TBL] [Abstract][Full Text] [Related]
10. High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia.
Mehrany K; Weenig RH; Pittelkow MR; Roenigk RK; Otley CC
Arch Dermatol; 2004 Aug; 140(8):985-8. PubMed ID: 15313816
[TBL] [Abstract][Full Text] [Related]
11. Incompletely excised basal cell carcinoma: residual tumor rates at Mohs re-excision.
Palmer VM; Wilson PR
Dermatol Surg; 2013 May; 39(5):706-18. PubMed ID: 23294110
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of serial transverse cross-sections in detecting residual basal cell carcinoma at the surgical margins of an elliptical excision specimen.
Kimyai-Asadi A; Goldberg LH; Jih MH
J Am Acad Dermatol; 2005 Sep; 53(3):469-74. PubMed ID: 16112355
[TBL] [Abstract][Full Text] [Related]
13. Incidence of invasive squamous cell carcinomas in biopsy-proven squamous cell carcinomas in situ sent for Mohs micrographic surgery.
Chuang GS; Lu LK; Cummins DL; Wu H; Finn D; Rogers GS; Lee D
Dermatol Surg; 2012 Sep; 38(9):1456-60. PubMed ID: 22734860
[TBL] [Abstract][Full Text] [Related]
14. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years.
Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
J Am Acad Dermatol; 2005 Sep; 53(3):445-51. PubMed ID: 16112351
[TBL] [Abstract][Full Text] [Related]
15. Formalin-fixed tissue Mohs surgery (slow Mohs) for basal cell carcinoma: 5-year follow-up data.
Lawrence CM; Haniffa M; Dahl MG
Br J Dermatol; 2009 Mar; 160(3):573-80. PubMed ID: 19210500
[TBL] [Abstract][Full Text] [Related]
16. Perianal and genital basal cell carcinoma: A clinicopathologic review of 51 cases.
Gibson GE; Ahmed I
J Am Acad Dermatol; 2001 Jul; 45(1):68-71. PubMed ID: 11423837
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of narrow-margin excision of well-demarcated primary facial basal cell carcinomas.
Kimyai-Asadi A; Alam M; Goldberg LH; Peterson SR; Silapunt S; Jih MH
J Am Acad Dermatol; 2005 Sep; 53(3):464-8. PubMed ID: 16112354
[TBL] [Abstract][Full Text] [Related]
18. Difference between pigmented and nonpigmented basal cell carcinoma treated with Mohs micrographic surgery.
Aoyagi S; Nouri K
Dermatol Surg; 2006 Nov; 32(11):1375-9. PubMed ID: 17083591
[TBL] [Abstract][Full Text] [Related]
19. A comparison of touch imprint cytology and Mohs frozen-section histology in the evaluation of Mohs micrographic surgical margins.
Florell SR; Layfield LJ; Gerwels JW
J Am Acad Dermatol; 2001 Apr; 44(4):660-4. PubMed ID: 11260543
[TBL] [Abstract][Full Text] [Related]
20. Adamantinoid basal cell carcinoma: a predictor of more-aggressive clinical behavior.
Berk DR; Ball Arefiev KL; Gladstone HB
Dermatol Surg; 2012 Aug; 38(8):1346-50. PubMed ID: 22551358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]